Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory - sprookjes - yvandenbroek - TriplyDB

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

http://www.wikidata.org/entity/Q24644260

about

Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay.Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.Metaplasticity of the late-phase of long-term potentiation: a critical role for protein kinase A in synaptic tagging A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4 Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway PDE4 as a target for cognition enhancement Phosphodiesterase inhibition increases CREB phosphorylation and restores orientation selectivity in a model of fetal alcohol spectrum disorders Psychiatric aspects of phosphodiesterases: An overview.Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change Phosphodiesterases as therapeutic targets for Alzheimer's disease.Environmental enrichment modifies the PKA-dependence of hippocampal LTP and improves hippocampus-dependent memory RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5 Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway ERK regulation of phosphodiesterase 4 enhances dopamine-stimulated AMPA receptor membrane insertion A biphasic and brain-region selective down-regulation of cyclic adenosine monophosphate concentrations supports object recognition in the rat Impaired spatial learning and memory after sevoflurane-nitrous oxide anesthesia in aged rats is associated with down-regulated cAMP/CREB signaling GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs Translating the frontiers of brain repair to treatments: starting not to break the rules Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model.Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Epac signaling is required for hippocampus-dependent memory retrieval.PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.Zebrafish: An in vivo model for the study of neurological diseases.The cyclic AMP cascade is altered in the fragile X nervous system Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.Viagra for your synapses: Enhancement of hippocampal long-term potentiation by activation of beta-adrenergic receptors.Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases Phosphodiesterase type 1 inhibition improves learning in rats exposed to alcohol during the third trimester equivalent of human gestation Phosphodiesterase type 4 inhibition does not restore ocular dominance plasticity in a ferret model of fetal alcohol spectrum disorders.Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory.Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism.A novel conditional genetic system reveals that increasing neuronal cAMP enhances memory and retrieval.Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase Intracellular membrane association of the Aplysia cAMP phosphodiesterase long and short forms via different targeting mechanisms.Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling

P2860

Q24297532-502A8DC8-A22A-4197-90C7-17CA64DC830D Q24609188-B699290A-0084-4F15-BFB0-7A216F14D73C Q24631756-8120DFA3-DDFD-48F3-B0F4-973BD25E315C Q24683143-8C07D66E-A0CC-4642-8F2D-E935448CBB42 Q24684042-00B3802D-20F8-4820-B3DD-58FFC545CD34 Q27008296-6CFBBF0C-7BAE-4788-A376-7380FA1104E4 Q27344585-D7C77A04-41B7-4E9F-8DF2-1D60E914DA54 Q28078128-E5526AF6-C7EA-468E-BFCC-D0DD3BE54177 Q28261760-1C504813-CEFA-4944-9F12-179833A54E8E Q28279704-B28B2005-24AA-46C7-8201-38D48508347C Q28346604-BFB4BADB-0685-4D82-B852-EE59CD928A9C Q28386161-1D976F70-380C-4FFC-BE80-55C8D79AA077 Q28387166-1CA6CCFC-A59B-456B-8EF6-BB4CDCB56079 Q28388995-AFE9F890-EA4C-47FF-A830-E8F762ED0F0C Q28480922-CE146D68-76A7-42ED-AFD7-26D6B0A7DD68 Q28535169-5FE1101A-A8AA-463A-A2D2-68E4E0BD16BD Q28564847-168C599B-F50A-474F-944F-3D5B11694D05 Q28570971-5504B7A4-2D3C-49C8-8EB3-CFD28E222116 Q28748979-E54FF1DC-E97E-4A6B-A74F-7C757810D3FB Q30362378-782D2238-598C-4DE7-AF34-F7A442F3CFF2 Q30408186-523E8C34-3131-4293-9C48-61D70C8C9C12 Q30440218-618AF43D-43DB-4B08-8BF7-5FF745301658 Q30468797-2DD15BC8-B14F-45D3-BD89-DD2A2D03B023 Q30469285-9668F1C2-71C8-4DE9-970C-95EECA33881E Q30469594-6E3AC1FF-FD6B-4348-B34D-68B168591D74 Q30478804-EF30B251-E428-495C-9BE8-A748888F29FD Q30493208-4DAA342F-0592-4A60-90C7-C5BF9A669FCD Q33300336-0BD4969C-7B6E-48BD-B976-4E6BAF4F6B33 Q33564436-7C059E78-81B8-4A7E-9B19-B5DC73B50FB8 Q33624262-B3136B09-8755-4139-9311-A1F9C94F1799 Q33678921-FD79F32B-CA19-49EF-B2F1-901C17A2885E Q33679220-044B22E6-815F-4899-9288-FA207B4B898A Q33761921-E52D4457-D593-42FD-8CEF-C2860B5B055D Q33800535-4D2DCD07-C8E4-4091-A4E4-1DB38A0092F3 Q34000281-62C87EC6-8DA3-437B-A1D8-A840C10278F2 Q34016340-AEC7AF9F-22F3-46B2-91D8-F6DA5FEB31A1 Q34017893-E27A591E-FD51-41AF-8B0F-5F616FE72777 Q34037728-FC989DF7-258B-4C29-83DD-A98D63CC6833 Q34170786-7F1BD553-2A9D-495D-A2EA-F7EC482CE938 Q34192226-0912877D-4A27-44FD-85D6-44BD094A900C

P2860

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

http://www.wikidata.org/entity/Q24644260

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Rolipram, a type IV-specific p ...... tentiation and improves memory

@ast

Rolipram, a type IV-specific p ...... tentiation and improves memory

@en

Rolipram, a type IV-specific p ...... tentiation and improves memory

@nl

type

label

Rolipram, a type IV-specific p ...... tentiation and improves memory

@ast

Rolipram, a type IV-specific p ...... tentiation and improves memory

@en

Rolipram, a type IV-specific p ...... tentiation and improves memory

@nl

prefLabel

Rolipram, a type IV-specific p ...... tentiation and improves memory

@ast

Rolipram, a type IV-specific p ...... tentiation and improves memory

@en

Rolipram, a type IV-specific p ...... tentiation and improves memory

@nl

P1433

Q24644260-78B09A39-CC29-4CA7-95E7-868987A3D863

P1476

Q24644260-58344682-F8B6-496C-9A43-AB200E0D3DC0

P2093

Q24644260-2F09A599-55E2-4202-97E3-2DA9B99439B3

Q24644260-ADC67E31-06E2-4AE7-BEC7-67C87FB8F258

Q24644260-D8AAC905-5BFA-42FC-A47C-7B732916BC65

Q24644260-DF284AC5-7148-4CBF-97C0-FF523DDF6843

P2860

Q24644260-03164F8C-373A-40EA-8DC3-AD83968F4FE4

Q24644260-0FF8CC0F-1A1D-4870-B4EF-28F149EECA72

Q24644260-16CB2F69-1B9F-451B-AB7E-63DCDDF9EFE9

Q24644260-2123F1A3-F6F2-41CD-B795-28B98FBD08E5

Q24644260-3BB91E79-53EA-42A6-B4CE-C81043DA9D16

Q24644260-4330481E-53D9-459A-AEDE-BB6383A363A9

Q24644260-46DE1F82-9CB1-45DD-A481-04795D49D7DE

Q24644260-4B1D2615-AA54-43B3-9FD0-E26BC6F6A8F2

Q24644260-4DADAA72-0315-4DE4-9009-072AC17BFD38

Q24644260-54511B2F-B6F5-4E15-B4DB-1773F691DCC7

P304

Q24644260-C52CE968-040C-4FCC-8468-42FB37697C2D

P31

Q24644260-128C52BE-04C9-41BB-9458-DBCF84D5C014

P3181

Q24644260-E8E019D2-8E2A-4F71-BDC1-90066B34A1EB

P356

Q24644260-C6CE7556-EF2F-4089-B5E2-09F1FB8E3439

P407

Q24644260-5ED03627-D18F-42F3-9500-7EC829BE8719

P433

Q24644260-C7BF2D87-A148-4A14-949F-A5239A4FDDEA

P478

Q24644260-52ADED29-478A-402F-A20E-2E60ECD76808

P50

Q24644260-12A9B724-3A48-4E22-ACF0-8C6D945B8402

P577

Q24644260-0C3738E0-F082-463D-B817-571FBF8F192E

P5875

Q24644260-A149DFFF-7D8A-457E-B98F-03275871A454

P698

Q24644260-003B11A0-A6B2-40D2-8EAB-5F93485382A0

P932

Q24644260-68C40236-A5B2-4E7A-A607-1B0B872807EC

P3181

P356

PNAS.95.25.15020

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Rolipram, a type IV-specific p ...... tentiation and improves memory

@en

P2093

D G Winder

http://www.w3.org/2001/XMLSchema#string

H Golan

http://www.w3.org/2001/XMLSchema#string

M Barad

http://www.w3.org/2001/XMLSchema#string

R Bourtchouladze

http://www.w3.org/2001/XMLSchema#string

P2860

A synaptic model of memory: long-term potentiation in the hippocampus

Regulation of adenylyl cyclase by protein kinase A

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

Long-lasting forms of synaptic potentiation in the mammalian hippocampus.

Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene.

Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro.

Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.

Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.

Requirement of a critical period of transcription for induction of a late phase of LTP.

P304

15020-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1304471

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.95.25.15020

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13443741

http://www.w3.org/2001/XMLSchema#string

P698

9844008

http://www.w3.org/2001/XMLSchema#string

P932

24568

http://www.w3.org/2001/XMLSchema#string